search
Back to results

Chat-based Support for Preventing Smoking Relapse

Primary Purpose

Smoking Cessation

Status
Completed
Phase
Not Applicable
Locations
Hong Kong
Study Type
Interventional
Intervention
Chat-based instant messaging support
SMS message support
Self-help booklet
Sponsored by
The University of Hong Kong
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Smoking Cessation focused on measuring Instant messaging, Relapse prevention, WhatsApp, WeChat, Chat intervention, Chinese, Mobile health

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Hong Kong residents aged 18 years or older
  • Enrolled in a smoking cessation programme under Tung Wah Group of Hospitals Integrated Centre on Smoking Cessation
  • Daily tobacco use before service intake
  • Not using any tobacco product for 3 to 30 days
  • Own a mobile phone with a mobile instant messaging app (WhatsApp or WeChat) installed
  • Able to communicate in Chinese (Cantonese or Mandarin)

Exclusion Criteria:

  • Subjects with communication barriers owing to physical or cognitive conditions will be excluded.

Sites / Locations

  • Tung Wah Group of Hospitals Integrated Centre on Smoking Cessation

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Intervention group

Control group

Arm Description

Chat-based instant messaging support + Self-help booklet

SMS message support + Self-help booklet

Outcomes

Primary Outcome Measures

Biochemically-validated tobacco abstinence
Defined by an exhaled carbon monoxide level of 3 parts per million or below

Secondary Outcome Measures

Self-reported 6-month prolonged tobacco abstinence
Not more than five lapses permitted for 6 months after baseline
Self-reported 7-day point-prevalence tobacco abstinence
Being completely smoke-free in the past 7 days
Self-reported 7-day point-prevalence tobacco abstinence
Being completely smoke-free in the past 7 days
Self-reported relapse rate
Defined as use of tobacco products for 7 consecutive days or longer
Self-reported relapse rate
Defined as use of tobacco products for 7 consecutive days or longer

Full Information

First Posted
May 26, 2020
Last Updated
March 2, 2021
Sponsor
The University of Hong Kong
search

1. Study Identification

Unique Protocol Identification Number
NCT04409496
Brief Title
Chat-based Support for Preventing Smoking Relapse
Official Title
Chat-based Instant Messaging Support for Preventing Smoking Relapse in the Context of COVID-19 Outbreak: a Pilot Randomised Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
March 2021
Overall Recruitment Status
Completed
Study Start Date
June 2, 2020 (Actual)
Primary Completion Date
January 22, 2021 (Actual)
Study Completion Date
January 22, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The University of Hong Kong

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This pilot trial aims to evaluate the effectiveness of chat-based instant messaging support in preventing smoking relapse in recent tobacco abstainers.
Detailed Description
Smoking cessation is one of the most cost-effective health interventions, which can add up to 10 years of life expectancy (Jha et al., 2013). However, it is very difficult to quit smoking because of the addictive effect of nicotine presents in tobacco products, and smokers typically make multiple attempts before successfully quit smoking. Providing evidence-based treatment could substantially increase the chance of successful quitting. The Coronavirus Disease 2019 (COVID-19) provided new opportunities and challenges in promoting smoking cessation. A growing literature has shown that smoking is linked to poor progression of COVID-19 (Patanavanich & Glantz, 2020), which can be a new warning for motivating smokers to quit smoking. However, social distancing measures and increased stress and anxiety related to fear of contracting COVID-19 may increase the risk of smoking relapse in people who recently quit smoking (Patwardhan, 2020). There are also misinformation or unproven claims that smoking can protect against COVID-19. The social distancing measures also become a barrier for smokers who are interested in quitting to receive treatment from smoking cessation clinics. Therefore, implementing new interventions that can address the challenges in the context of the COVID-19 pandemic is needed. Advance in mobile technologies provides a new avenue for delivering smoking cessation support. A qualitative interview of 21 current smokers in Hong Kong has found that mobile instant messaging app (e.g., WhatsApp) is an acceptable and feasible platform for providing chat support for smoking cessation (Luk et al., 2019). Chat-based support allows a registered nurse or trained counsellor to interact with a smoker individually through mobile instant messaging apps (e.g., WhatsApp and WeChat) and provide real-time, continuous, and personalized smoking cessation information and advice. A randomised trial of 1185 smokers found that the chat-based intervention integrated with brief intervention was effective in increasing smoking cessation (Wang et al., 2019). The trial also provided initial evidence that the intervention can be delivered as a stand-alone treatment or in combination with use of existing cessation treatment, to increase the chance of successful quitting. This study aims to adapt the chat intervention for smoking relapse prevention and evaluate its feasibility and effectiveness in recent tobacco abstainers enrolled in a clinic-based smoking cessation service in Hong Kong.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Smoking Cessation
Keywords
Instant messaging, Relapse prevention, WhatsApp, WeChat, Chat intervention, Chinese, Mobile health

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
108 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Intervention group
Arm Type
Experimental
Arm Description
Chat-based instant messaging support + Self-help booklet
Arm Title
Control group
Arm Type
Active Comparator
Arm Description
SMS message support + Self-help booklet
Intervention Type
Behavioral
Intervention Name(s)
Chat-based instant messaging support
Intervention Description
Subjects will receive personalised instant messaging support for 12 weeks after baseline, address the five problems that contributed to smoking relapse: (1) lack of support for cessation, (2) negative mood or depression, (3) strong or prolonged withdrawal symptoms, (4) weight gain, and (5) smoking lapses. Updated information about the negative effect of smoking on risk of COVID-19 infection and prognosis will also be delivered.
Intervention Type
Behavioral
Intervention Name(s)
SMS message support
Intervention Description
Subjects will receive regular SMS on generic smoking cessation for 3 months.
Intervention Type
Behavioral
Intervention Name(s)
Self-help booklet
Intervention Description
Subjects will receive a standard self-help booklet on smoking relapse prevention.
Primary Outcome Measure Information:
Title
Biochemically-validated tobacco abstinence
Description
Defined by an exhaled carbon monoxide level of 3 parts per million or below
Time Frame
Assessed at 6 months after randomisation
Secondary Outcome Measure Information:
Title
Self-reported 6-month prolonged tobacco abstinence
Description
Not more than five lapses permitted for 6 months after baseline
Time Frame
Assessed at 6 months after randomisation
Title
Self-reported 7-day point-prevalence tobacco abstinence
Description
Being completely smoke-free in the past 7 days
Time Frame
Assessed at 3 months after randomisation
Title
Self-reported 7-day point-prevalence tobacco abstinence
Description
Being completely smoke-free in the past 7 days
Time Frame
Assessed at 6 months after randomisation
Title
Self-reported relapse rate
Description
Defined as use of tobacco products for 7 consecutive days or longer
Time Frame
Assessed at 3 months after randomisation
Title
Self-reported relapse rate
Description
Defined as use of tobacco products for 7 consecutive days or longer
Time Frame
Assessed at 6 months after randomisation
Other Pre-specified Outcome Measures:
Title
Change in self-efficacy to quit smoking
Description
Assessed by the Chinese version of the Smoking Self-efficacy Questionnaire (SEQ-12), which contains 12 Likert items ranging from 1 (not certain at all) to 5 (very certain) with higher scores indicating greater perceived confidence in resisting smoking.
Time Frame
Assessed at 3 months after randomisation
Title
Change in self-efficacy to quit smoking
Description
Assessed by the Chinese version of the Smoking Self-efficacy Questionnaire (SEQ-12), which contains 12 Likert items ranging from 1 (not certain at all) to 5 (very certain) with higher scores indicating greater perceived confidence in resisting smoking.
Time Frame
Assessed at 6 months after randomisation
Title
Nicotine withdrawal
Description
Assessed by the Chinese verion of the Minnesota Nicotine Withdrawal Scale (MNWS), which contains 9 Likert items ranging from 0 (not at all) to 4 (very severe) with higher scores indicating greater nicotine withdrawal.
Time Frame
Assessed at 3 months after randomisation
Title
Nicotine withdrawal
Description
Assessed by the Chinese verion of the Minnesota Nicotine Withdrawal Scale (MNWS), which contains 9 Likert items ranging from 0 (not at all) to 4 (very severe) with higher scores indicating greater nicotine withdrawal.
Time Frame
Assessed at 6 months after randomisation

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Hong Kong residents aged 18 years or older Enrolled in a smoking cessation programme under Tung Wah Group of Hospitals Integrated Centre on Smoking Cessation Daily tobacco use before service intake Not using any tobacco product for 3 to 30 days Own a mobile phone with a mobile instant messaging app (WhatsApp or WeChat) installed Able to communicate in Chinese (Cantonese or Mandarin) Exclusion Criteria: Subjects with communication barriers owing to physical or cognitive conditions will be excluded.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Tzu Tsun Luk, PhD, RN
Organizational Affiliation
The University of Hong Kong
Official's Role
Principal Investigator
Facility Information:
Facility Name
Tung Wah Group of Hospitals Integrated Centre on Smoking Cessation
City
Hong Kong
Country
Hong Kong

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
23343063
Citation
Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN, McAfee T, Peto R. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med. 2013 Jan 24;368(4):341-50. doi: 10.1056/NEJMsa1211128.
Results Reference
background
PubMed Identifier
32399563
Citation
Patanavanich R, Glantz SA. Smoking Is Associated With COVID-19 Progression: A Meta-analysis. Nicotine Tob Res. 2020 Aug 24;22(9):1653-1656. doi: 10.1093/ntr/ntaa082.
Results Reference
background
PubMed Identifier
32265183
Citation
Patwardhan P. COVID-19: Risk of increase in smoking rates among England's 6 million smokers and relapse among England's 11 million ex-smokers. BJGP Open. 2020 Jun 23;4(2):bjgpopen20X101067. doi: 10.3399/bjgpopen20X101067. Print 2020. No abstract available. Erratum In: BJGP Open. 2021 Feb 23;5(1):
Results Reference
background
PubMed Identifier
30702431
Citation
Luk TT, Wong SW, Lee JJ, Chan SS, Lam TH, Wang MP. Exploring Community Smokers' Perspectives for Developing a Chat-Based Smoking Cessation Intervention Delivered Through Mobile Instant Messaging: Qualitative Study. JMIR Mhealth Uhealth. 2019 Jan 31;7(1):e11954. doi: 10.2196/11954.
Results Reference
background
PubMed Identifier
33323188
Citation
Wang MP, Luk TT, Wu Y, Li WH, Cheung DY, Kwong AC, Lai V, Chan SS, Lam TH. Chat-based instant messaging support integrated with brief interventions for smoking cessation: a community-based, pragmatic, cluster-randomised controlled trial. Lancet Digit Health. 2019 Aug;1(4):e183-e192. doi: 10.1016/S2589-7500(19)30082-2. Epub 2019 Jul 31.
Results Reference
background
PubMed Identifier
35166327
Citation
Luk TT, Cheung YTD, Chan HC, Fok PW, Ho KS, Sze CD, Lam TH, Wang MP. Mobile Chat Messaging for Preventing Smoking Relapse Amid the COVID-19 Pandemic: A Pilot Randomized Controlled Trial. Nicotine Tob Res. 2023 Jan 5;25(2):291-297. doi: 10.1093/ntr/ntac045.
Results Reference
derived

Learn more about this trial

Chat-based Support for Preventing Smoking Relapse

We'll reach out to this number within 24 hrs